KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 123 filers reported holding KRYSTAL BIOTECH INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $103,000 | -61.6% | 1,975 | -50.0% | 0.00% | – |
| Q2 2021 | $268,000 | -11.8% | 3,950 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $304,000 | -76.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,304,000 | +667.1% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $170,000 | +3.7% | 3,950 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $164,000 | +925.0% | 3,950 | +953.3% | 0.00% | – |
| Q1 2020 | $16,000 | -23.8% | 375 | 0.0% | 0.00% | – |
| Q4 2019 | $21,000 | -89.5% | 375 | -93.5% | 0.00% | -100.0% |
| Q3 2019 | $200,000 | +51.5% | 5,765 | +76.0% | 0.00% | 0.0% |
| Q2 2019 | $132,000 | +22.2% | 3,275 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $108,000 | +77.0% | 3,275 | +12.0% | 0.00% | 0.0% |
| Q4 2018 | $61,000 | +56.4% | 2,925 | +31.5% | 0.00% | – |
| Q3 2018 | $39,000 | +18.2% | 2,225 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +50.0% | 2,225 | 0.0% | 0.00% | – |
| Q1 2018 | $22,000 | +100.0% | 2,225 | +122.5% | 0.00% | – |
| Q4 2017 | $11,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |